Norio Nonomura

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study

Shunsuke Inoguchi, Atsunari Kawashima, Yu Ishizuya, Takuji Hayashi et autres

This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.This version will undergo additional copyediting,

jp (code pays fourni par la source)

Successful Treatment of Primary Mediastinal Seminoma With Radiotherapy Following Chemotherapy Under a Bloodless Treatment Policy Based on Patient's Religious Sentiments

Eisuke Fujii, Yoshiyuki Yamamoto, Kentaro Takezawa, Koji Hatano et autres

Introduction: Primary mediastinal seminoma is rare with a favorable prognosis when appropriately treated, and surgical resection after chemotherapy is the standard treatment. However, refusal of blood transfusion for religious reasons can limit curative surgical management. Case Presentation: A 47-year-old Jehovah's Witness man …

jp (code pays fourni par la source)

Consensus‐Based Development of a Surgical Checklist for Transurethral Resection of Bladder Tumor: An Initiative of the Japanese Society of Urologic Oncology

Rikiya Taoka, Nozomi Hayakawa, Tomokazu Kimura, Eiji Kikuchi et autres

OBJECTIVE: This study aimed to develop a nationwide, consensus-based surgical checklist to standardize transurethral resection of bladder tumor procedures and documentation. METHODS: In 2025, the Japanese Society of Urologic Oncology convened a working group of 20 bladder cancer specialist urologists to develop …

jp (code pays fourni par la source)

Acute Cardiac Tamponade Following Enfortumab Vedotin Initiation in Metastatic Urothelial Carcinoma: Successful Rescue by Pericardial Fenestration

Hiroto Akamatsu, Yu Ishizuya, Kentaro Takezawa, Taigo Kato et autres

Introduction: Enfortumab vedotin is a Nectin-4-directed antibody-drug conjugate approved for metastatic urothelial carcinoma. Cardiac adverse events such as pericardial effusion or tamponade associated with enfortumab vedotin are extremely rare. Case Presentation: A 50-year-old man with metastatic UC developed chest pain and dyspnea …

jp (code pays fourni par la source)

Primary mediastinal germ cell tumor in an 88-year-old man managed with carboplatin monotherapy and radiotherapy

Hiroki Kodani, Shigeaki Nakazawa, Yu Ishizuya, Yoshiyuki Yamamoto et autres

jp (code pays fourni par la source)

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer

Yu Ishizuya, Atsunari Kawashima, Shimpei Yamashita, Takeshi Ujike et autres

Abstract Objective This study aimed to evaluate whether the preoperative FAN score—composed of the fibrosis‐4 (Fib‐4) index, albumin–bilirubin (ALBI) score and neutrophil–lymphocyte ratio (NLR)—predicts recurrence‐free, cancer‐specific and overall survival after radical cystectomy for bladder cancer. Patients and Methods We retrospectively analysed 1121 …

jp (code pays fourni par la source)

IP33-07 DEVELOPMENT AND CLINICAL UTILITY OF THE SODIUM EXCRETION SHIFT INDEX: A TWO-SPOT URINE APPROACH TO EVALUATE NOCTURNAL POLYURIA

Norichika Ueda, Teppei Wakita, Yuma Kujime, Hiroaki Kitakaze et autres

IP15-10 COMPREHENSIVE IDENTIFICATION OF FACTORS ASSOCIATED WITH WORSENING MALE LOWER URINARY TRACT SYMPTOMS VIA META-16S ANALYSIS USING A LARGE HUMAN GUT MICROBIOTA DATABASE

Junya Hata, Saizo Fujimoto, Toshiki Oka, Makoto Matsushita et autres

IP38-05 DEVELOPMENT AND CLINICAL IMPLEMENTATION OF A SIMPLE RADIUM-223 NON-COMPLETION RISK CALCULATOR FOR BONE-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Hiroshi Yaegashi, Takuma Kato, Kazutoshi Fujita, Toru Harabayashi et autres

GG02-40 EXERCISE INHIBITS PROSTATE CANCER PROGRESSION BY SUPPRESSING ARGINASE1

Toshiki Oka, Koji Hatano, Hiroaki Hase, Masatoshi Konishi et autres

IP11-30 USEFULNESS OF SCREENING FOR UROLOGICAL MALIGNANCIES AFTER KIDNEY TRANSPLANTATION

Yoichi Kakuta, Soichi Matsumura, Shota Fukae, Masataka Kawamura et autres

IP83-26 REAL-WORLD TREATMENT PATTERNS AND SURVIVAL OUTCOMES IN METASTATIC UROTHELIAL CARCINOMA IN THE ENFORTUMAB VEDOTIN ERA: IMPACT OF FIRST-LINE ENFORTUMAB VEDOTIN PLUS PEMBROLIZUMAB VERSUS PLATINUM CHEMOTHERAPY

Atsunari Kawashima, Takeshi Ujike, Yujiro Hayashi, Ayuko Higaki et autres